Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock - Currency: USD

20.42  0 (0%)

After market: 20.42 0 (0%)

Fundamental Rating

3

Taking everything into account, MIR scores 3 out of 10 in our fundamental rating. MIR was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. There are concerns on the financial health of MIR while its profitability can be described as average. MIR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MIR was profitable.
In the past year MIR had a positive cash flow from operations.
MIR had negative earnings in each of the past 5 years.
In the past 5 years MIR always reported a positive cash flow from operatings.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.38%, MIR is in line with its industry, outperforming 49.60% of the companies in the same industry.
The Return On Equity of MIR (-0.66%) is comparable to the rest of the industry.
The Return On Invested Capital of MIR (1.34%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.38%
ROE -0.66%
ROIC 1.34%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

MIR's Operating Margin of 4.61% is fine compared to the rest of the industry. MIR outperforms 63.20% of its industry peers.
MIR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.97%, MIR belongs to the top of the industry, outperforming 80.80% of the companies in the same industry.
In the last couple of years the Gross Margin of MIR has grown nicely.
Industry RankSector Rank
OM 4.61%
PM (TTM) N/A
GM 46.97%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MIR is destroying value.
The number of shares outstanding for MIR has been increased compared to 1 year ago.
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.77 indicates that MIR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.77, MIR is doing worse than 63.20% of the companies in the same industry.
MIR has a debt to FCF ratio of 8.15. This is a slightly negative value and a sign of low solvency as MIR would need 8.15 years to pay back of all of its debts.
MIR's Debt to FCF ratio of 8.15 is in line compared to the rest of the industry. MIR outperforms 54.40% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that MIR is not too dependend on debt financing.
MIR has a Debt to Equity ratio of 0.46. This is in the lower half of the industry: MIR underperforms 66.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 8.15
Altman-Z 2.77
ROIC/WACC0.14
WACC9.49%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

MIR has a Current Ratio of 2.23. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR has a Current ratio of 2.23. This is comparable to the rest of the industry: MIR outperforms 47.20% of its industry peers.
MIR has a Quick Ratio of 1.69. This is a normal value and indicates that MIR is financially healthy and should not expect problems in meeting its short term obligations.
MIR's Quick ratio of 1.69 is in line compared to the rest of the industry. MIR outperforms 47.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.69
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.35% over the past year.
Looking at the last year, MIR shows a small growth in Revenue. The Revenue has grown by 7.25% in the last year.
MIR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.36% yearly.
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%4.88%

3.2 Future

Based on estimates for the next years, MIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.86% on average per year.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y17.8%
EPS Next 2Y17.87%
EPS Next 3Y19.86%
EPS Next 5YN/A
Revenue Next Year6.55%
Revenue Next 2Y7.03%
Revenue Next 3Y7.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 45.38, MIR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MIR is on the same level as its industry peers.
MIR is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
MIR is valuated quite expensively with a Price/Forward Earnings ratio of 35.85.
MIR's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of MIR to the average of the S&P500 Index (21.76), we can say MIR is valued expensively.
Industry RankSector Rank
PE 45.38
Fwd PE 35.85
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MIR.
The rest of the industry has a similar Price/Free Cash Flow ratio as MIR.
Industry RankSector Rank
P/FCF 56.25
EV/EBITDA 28.18
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MIR's earnings are expected to grow with 19.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.55
PEG (5Y)N/A
EPS Next 2Y17.87%
EPS Next 3Y19.86%

0

5. Dividend

5.1 Amount

MIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (7/11/2025, 8:04:01 PM)

After market: 20.42 0 (0%)

20.42

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-31 2025-07-31
Inst Owners82.68%
Inst Owner Change-0.35%
Ins Owners4.41%
Ins Owner Change0.53%
Market Cap4.74B
Analysts84.44
Price Target19.99 (-2.11%)
Short Float %6.28%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.41%
Min EPS beat(2)13.88%
Max EPS beat(2)26.94%
EPS beat(4)3
Avg EPS beat(4)15.21%
Min EPS beat(4)-11.99%
Max EPS beat(4)32.01%
EPS beat(8)6
Avg EPS beat(8)11.49%
EPS beat(12)8
Avg EPS beat(12)6.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.2%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)2.76%
Revenue beat(4)2
Avg Revenue beat(4)0.06%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)2.76%
Revenue beat(8)5
Avg Revenue beat(8)1.58%
Revenue beat(12)7
Avg Revenue beat(12)1.32%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.26%
PT rev (3m)-2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.67%
EPS NY rev (1m)-0.43%
EPS NY rev (3m)2.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 45.38
Fwd PE 35.85
P/S 5.44
P/FCF 56.25
P/OCF 36.8
P/B 3.15
P/tB N/A
EV/EBITDA 28.18
EPS(TTM)0.45
EY2.2%
EPS(NY)0.57
Fwd EY2.79%
FCF(TTM)0.36
FCFY1.78%
OCF(TTM)0.55
OCFY2.72%
SpS3.75
BVpS6.48
TBVpS-1.41
PEG (NY)2.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.66%
ROCE 1.7%
ROIC 1.34%
ROICexc 1.46%
ROICexgc 9.36%
OM 4.61%
PM (TTM) N/A
GM 46.97%
FCFM 9.68%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 8.15
Debt/EBITDA 3.7
Cap/Depr 30.63%
Cap/Sales 5.11%
Interest Coverage 0.77
Cash Conversion 69.42%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.69
Altman-Z 2.77
F-Score7
WACC9.49%
ROIC/WACC0.14
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y17.8%
EPS Next 2Y17.87%
EPS Next 3Y19.86%
EPS Next 5YN/A
Revenue 1Y (TTM)7.25%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%4.88%
Revenue Next Year6.55%
Revenue Next 2Y7.03%
Revenue Next 3Y7.12%
Revenue Next 5YN/A
EBIT growth 1Y707.58%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year381.68%
EBIT Next 3Y85%
EBIT Next 5YN/A
FCF growth 1Y1193.51%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y408.7%
OCF growth 3Y22.74%
OCF growth 5Y46.47%